Literature DB >> 22069109

Transplantation osteoporosis.

Sol Epstein1, Michal Stuss.   

Abstract

Transplantation provides a valuable, often life-saving, treatment for end-stage failure of many organs, including the heart, kidneys, liver, pancreas and lungs. It is also an important therapeutic option in diseases of the bone marrow and the immune system. Despite the undoubted benefits for transplant patients, it is associated with an increased risk of many complications. The potential causes include: poor general health of the patient, heavy burden of the surgery itself and the need for the long-term use of immunosuppression. In addition, the patients are also on numerous other medications, e.g. anti-coagulants, diuretics. Osteoporosis and high risk of fractures have emerged as frequent and devastating complications of the transplantation process. This article provides a review of the current literature on osteoporosis after transplantation, and the treatment options for this serious illness.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22069109

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  1 in total

1.  Clinical efficacy and safety of pamidronate therapy on bone mass density in early post-renal transplant period: a meta-analysis of randomized controlled trials.

Authors:  Zijie Wang; Zhijian Han; Jun Tao; Pei Lu; Xuzhong Liu; Jun Wang; Bian Wu; Zhengkai Huang; Changjun Yin; Ruoyun Tan; Min Gu
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.